March 11, 2013 -- Bedfont announce that the GastroCH4ECK™ is now available in the US following regulatory approval from the US Food and Drug Administration (FDA).
The GastroCH4ECK™ is a portable breath monitor that measures Hydrogen (H2), Methane (CH4) and Oxyge(O2) for the purpose of aiding the diagnosis of gastrointestinal conditions such as:
• Carbohydrate Breakdown Deficiency
• Lactose Intolerance
• Small instestinal Bacterial Overgrowth (SIBO)
• Determination of time passage through gut
• Irritable Bowel Syndrome (IBS)
The GastroCH4ECK™ allows health professionals to accurately detect a range of gastrointestinal disorders. An O2 reading is taken to motivate patients into providing an end-tidal sample. If the patient is unable to do this the GastroCH4ECK™ will automatically correct the reading saving the patient from embarrassment and having to carry out another test.
For more information, please visit www.bedfont.com or call 01622 851122
Click for How to use the GastroCH4ECK Gastrolyzer from Bedfont Scientific Ltd